Options -- The Striking Price: Cut Your Tax Bill Using This Options Strategy -- Barron's
Cathie Wood's ARK Buys CRISPR, Intellia Stock, Sells Moderna
Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season
Trending Tickers: Netflix, Ferrari, American Express, Moderna and Boohoo
Moderna Options Spot-On: On October 17th, 122.91K Contracts Were Traded, With 554.07K Open Interest
On October 17th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 122.91K options for the day, of which put options accounted for 82.14% of the total transactions,
Moderna plans to launch a combined vaccine for COVID-19 and influenza in Japan.
According to Kyodo News on October 17, Modena, a company from the USA, announced on October 17 that they are striving to launch a mixed vaccine for COVID-19 and seasonal influenza in Japan by 2027. CEO Stéphane Bancel mentioned that they are preparing the documents to be submitted to the Japanese Ministry of Health, Labor, and Welfare, hoping to apply within about half a year to a year. The company explained that if the vaccine they are developing can be put into practical use, one dose can provide two types of immunity, potentially reducing the burden on medical institutions and vaccine recipients.
Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Helfie AI Appoints Healthcare Industry Leaders Antonin De Fougerolles and Cheryl Buxton to the Board of Directors
Express News | Moderna : Bernstein Initiates Coverage With Market-Perform Rating; Target Price $55
Northwestern University in the usa sues moderna (MRNA.US) for infringement of its LNP patent technology.
On Wednesday, Northwestern University in the USA filed a new patent lawsuit against moderna in the Federal Court of Delaware, accusing the company of abusing the school's innovative results to develop its flagship COVID-19 vaccine, Spikevax.
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
Cathie Wood's ARK Sells Moderna, Buys More Intellia and Tempus Stock
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Moderna, Inc. (MRNA) the Most Promising Biotech Stock According to Hedge Funds?
Moderna Stock Falls 20% in a Month: Time to Sell or Hold?
F. William Studier Receives the 2024 Merkin Prize in Ceremony at the Broad Institute for Developing Technology Used to Produce Millions of Doses of COVID-19 Vaccines
Use This 'Double Up' Options Strategy to Cut Your Tax Bill
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
Moderna Continues to Be the Most Shorted S&P 500 Healthcare Stock in September
Unveiling 18 Analyst Insights On Moderna